Transdermal delivery systems

The present invention relates to a transdermal delivery system for administering sufentanil, through the skin, wherein said system provides a dosage form rate control over flux of sufentanil from the system and a net flux from the system through the skin of at least about 1 µg/cm 2 /hour, and furthe...

Full description

Saved in:
Bibliographic Details
Main Authors THEEUWES, FELIX, YUM, SU IL
Format Patent
LanguageEnglish
French
German
Published 04.04.2012
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a transdermal delivery system for administering sufentanil, through the skin, wherein said system provides a dosage form rate control over flux of sufentanil from the system and a net flux from the system through the skin of at least about 1 µg/cm 2 /hour, and further wherein said system does not contain a permeation enhancer.
Bibliography:Application Number: EP20100003544